R-1-Hydroxy-1-phenyl-2-propanone L-Phenylacetylcarbinol L-PAC CAS: 1798-60-3

CAS NO: 1798-60-3
R-1-Hydroxy-1-phenyl-2-propanone L-Phenylacetylcarbinol L-PAC
Chemical Name: (R)-1-hydroxy-1-phenylacetone
Molecular Formula: C9H10O2
Formula Weight: 150.17
CAS No.: 1798-60-3
Description Review
Description

R-1-Hydroxy-1-phenyl-2-propanone, also known as L-Phenylacetylcarbinol (L-PAC), is an organic compound with the molecular formula C9H10O2 and a formula weight of 150.17 g/mol. It has a CAS number of 1798-60-3 and is commonly used in the pharmaceutical and chemical industries as a synthetic intermediate. In this article, we will explore the top ten keywords related to L-PAC, along with its synonyms, health benefits, potential effects, product mechanism, safety, side effects, and dosing information.

Top Ten Keywords:

  1. L-Phenylacetylcarbinol
  2. R-1-Hydroxy-1-phenyl-2-propanone
  3. Enzymatic resolution
  4. Chiral auxiliary
  5. Asymmetric synthesis
  6. Intermediates
  7. Pharmaceuticals
  8. Chemical synthesis
  9. Optically active
  10. Stereoisomers

Synonyms:

  • 1-phenyl-1-hydroxy-2-propanone
  • L-PAC
  • Benzyl methyl ketone
  • Methyl benzoyl acetate
  • Phenylmethylketone
  • (S)-2-phenyl-2-hydroxyacetophenone
  • 1-phenylacetone-1-carbinol
  • 1-phenyl-2-propanol-1-ol

Health Benefits:

L-PAC has no direct health benefits for humans, as it is primarily used as a synthetic intermediate in the pharmaceutical and chemical industries. However, it can be used to synthesize pharmaceuticals that have therapeutic benefits for humans.

Potential Effects:

The potential effects of L-PAC are related to its use as a synthetic intermediate. L-PAC is commonly used in the manufacture of pharmaceuticals such as ephedrine and pseudoephedrine, which are used as decongestants and bronchodilators. Additionally, L-PAC can be used to synthesize chiral compounds using enzymatic resolution or chiral auxiliary methods, which can result in highly pure and optically active products.

Product Mechanism:

L-PAC is typically synthesized using chemical or enzymatic methods, resulting in a racemic mixture of the R and S enantiomers. The R enantiomer is the desired product, as it can be used to synthesize optically active compounds. L-PAC can also be used as an intermediate in the synthesis of other compounds, such as ephedrine and pseudoephedrine, which act as decongestants and bronchodilators.

Safety:

L-PAC is a moderately hazardous compound and should be handled with caution. It can cause skin and eye irritation, and inhalation of high concentrations can cause respiratory irritation, headache, dizziness, and nausea. L-PAC is also a flammable substance and should be stored in a cool, dry, and well-ventilated area away from ignition sources.

Side Effects:

L-PAC has no direct side effects on humans, as it is not intended for human consumption.

Dosing Information:

L-PAC dosing information is not relevant, as it is not intended for human consumption.

Conclusion:

L-Phenylacetylcarbinol (L-PAC) is a synthetic intermediate commonly used in the pharmaceutical and chemical industries. Its ability to be used as an intermediate in the synthesis of chiral compounds using enzymatic resolution or chiral auxiliary methods results in highly pure and optically active products. However, L-PAC should be handled with caution due to its moderate hazardous properties, and it is not intended for human consumption as a direct treatment.

Review
Review

ver_code
1/3
X
Send your message to us
please select your country
  • Afghanistan
  • Aland Islands
  • Albania
  • Algeria
  • American Samoa
  • Andorra
  • Angola
  • Anguilla
  • Antigua and Barbuda
  • Argentina
  • Armenia
  • Aruba
  • Australia
  • Austria
  • Azerbaijan
  • Bahamas
  • Bahrain
  • Bangladesh
  • Barbados
  • Belarus
  • Belgium
  • Belize
  • Benin
  • Bermuda
  • Bhutan
  • Bolivia
  • Bosnia and Herzegovina
  • Botswana
  • Bouvet Island
  • Brazil
  • British Indian Ocean Territory
  • British Virgin Islands
  • Brunei Darussalam
  • Bulgaria
  • Burkina Faso
  • Burundi
  • Cambodia
  • Cameroon
  • Canada
  • Cape Verde
  • Caribbean Netherlands
  • Cayman Islands
  • Central African Republic
  • Chad
  • Chile
  • China
  • Christmas Island
  • Cocos Islands
  • Colombia
  • Comoros
  • Congo
  • Cook Islands
  • Costa Rica
  • Cote D'ivoire
  • Cuba
  • Curaçao
  • Cyprus
  • Czech Republic
  • Democratic People's Republic of Korea
  • Democratic Republic of the Congo
  • Denmark
  • Djibouti
  • Dominica
  • East Timor
  • Ecuador
  • Egypt
  • El Salvador
  • Equatorial Guinea
  • Eritrea
  • Estonia
  • Ethiopia
  • Falkland Islands
  • Faroe Islands
  • Fiji
  • Finland
  • France
  • French Guiana
  • French Polynesia
  • French Southern Territories
  • Gabon
  • Gambia
  • Georgia
  • Germany
  • Ghana
  • Gibraltar
  • Greece
  • Greenland
  • Grenada
  • Guadeloupe
  • Guam
  • Guatemala
  • Guernsey
  • Guinea
  • Guinea-Bissau
  • Guyana
  • Haiti
  • Heard Island and Mcdonald Islands
  • Honduras
  • Hong Kong, China
  • Hungary
  • Iceland
  • India
  • Indonesia
  • Iran
  • Iraq
  • Ireland
  • Isle of Man
  • Israel
  • Italy
  • Jamaica
  • Japan
  • Jordan
  • Kazakhstan
  • Kenya
  • Kiribati
  • Korea
  • Kosovo
  • Kuwait
  • Kyrgyzstan
  • Laos
  • Latvia
  • Lebanon
  • Lesotho
  • Liberia
  • Liechtenstein
  • Lithuania
  • Luxembourg
  • Macau, China
  • Macedonia
  • Madagascar
  • Malawi
  • Malaysia
  • Maldives
  • Mali
  • Malta
  • Marshall Islands
  • Martinique
  • Mauritania
  • Mauritius
  • Mayotte
  • Mexico
  • Micronesia
  • Moldova
  • Monaco
  • Mongolia
  • Montenegro
  • Montserrat
  • Morocco
  • Mozambique
  • Myanmar
  • Namibia
  • Nauru
  • Nepal
  • Netherlands
  • Netherlands Antilles
  • New Caledonia
  • New Zealand
  • Nicaragua
  • Niger
  • Nigeria
  • Niue
  • Norfolk Island
  • Northern Mariana Islands
  • Norway
  • Oman
  • Pakistan
  • Palau
  • Palestine
  • Panama
  • Papua New Guinea
  • Paraguay
  • Peru
  • Philippines
  • Pitcairn Islands
  • Poland
  • Portugal
  • Puerto Rico
  • Qatar
  • Reunion
  • Romania
  • Russia
  • Rwanda
  • Saint Barthélemy
  • Saint Helena
  • Saint Kitts and Nevis
  • Saint Lucia
  • Saint Martin
  • Saint Pierre and Miquelon
  • Saint Vincent and the Grenadines
  • San Marino
  • Sao Tome and Principe
  • Saudi Arabia
  • Senegal
  • Serbia
  • Seychelles
  • Sierra Leone
  • Singapore
  • Sint Maarten
  • Slovakia
  • Slovenia
  • Solomon Islands
  • Somalia
  • South Africa
  • South Georgia and The South Sandwich Islands
  • Spain
  • Sri Lanka
  • State of Libya
  • Sudan
  • Suriname
  • Svalbard and Jan Mayen
  • Swaziland
  • Sweden
  • Switzerland
  • Syrian Arab Republic
  • TaiWan, China
  • Tajikistan
  • Tanzania
  • Thailand
  • The Republic of Croatia
  • Togo
  • Tokelau
  • Tonga
  • Trinidad and Tobago
  • Tunisia
  • Turkey
  • Turkmenistan
  • Turks and Caicos Islands
  • Tuvalu
  • Uganda
  • Ukraine
  • United Arab Emirates
  • United Kingdom
  • United States
  • United States Minor Outlying Islands
  • Uruguay
  • US Virgin Islands
  • Uzbekistan
  • Vanuatu
  • Vatican City State
  • Venezuela
  • Vietnam
  • Wallis and Futuna Islands
  • Western Sahara
  • Western Samoa
  • Yemen
  • Zambia
  • Zimbabwe
ver_code